Oculis Holding AG
OCS · XICE · Health Care · Ophthalmology · Pencatatan di AS: OCS
Tentang perusahaan
Oculis is a clinical-stage biopharmaceutical company focused on developing treatments for serious eye diseases. It is incorporated in Switzerland and listed on Nasdaq Iceland as well as Nasdaq US. The company's pipeline targets conditions including wet age-related macular degeneration and diabetic macular edema.
| Bursa | XICE |
| Kode saham | OCS |
| Sektor | Health Care · Ophthalmology |
| Pencatatan di AS | OCS |
| Kapitalisasi pasar indikatif USD | $465.00M |
| Situs web | Kunjungi situs web |
Harga langsung
Memuat harga terkini…
| Kapitalisasi pasar | |
| Kisaran harian | |
| Kisaran 52 minggu |
Cara membeli
Diperdagangkan di AS sebagai OCS, tersedia melalui sebagian besar akun pialang AS.
Di pasar asal (XICE), dapat diakses melalui broker global yang menawarkan bursa tersebut:
- Interactive Brokers — Direct access to 90+ markets worldwide, including many emerging exchanges.
- Saxo Bank — Multi-market access across Asia, Europe and the Middle East.
- Charles Schwab (Global) — Foreign ordinary shares on select markets; US-listed ADRs and ETFs.
- Fidelity International Trading — International stock trading on a number of developed and emerging markets.
- Nasdaq Iceland, the sole stock exchange in Iceland, is operated by Nasdaq Nordic and uses the trading code XICE. — pencatatan resmi di bursa
Hanya informasi ketersediaan, bukan rekomendasi atau penawaran untuk membeli. Konfirmasikan kelayakan, biaya, dan ketersediaan terkini dengan broker Anda.
Perusahaan lain di Iceland
Data perusahaan dan harga langsung apa pun bersifat indikatif, mungkin tertunda atau tidak akurat, dan hanya untuk riset, bukan saran investasi. Verifikasi dengan bursa, pengajuan perusahaan, dan broker Anda.